コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ciated with salivary gland MALT lymphoma (SG-MALT-lymphoma).
2 phoepithelial lesions, a hallmark of gastric MALT lymphoma.
3 may eventually develop into low-grade B-cell MALT lymphoma.
4 olution of H. pylori-associated gastritis to MALT lymphoma.
5 is associated with HP dependence of gastric MALT lymphoma.
6 atients with an increased risk of developing MALT lymphoma.
7 tion signature to that of the salivary gland MALT lymphoma.
8 varying size in four patients with low-grade MALT lymphoma.
9 patients initially diagnosed elsewhere with MALT lymphoma.
10 ic marginal zone in a single case of gastric MALT lymphoma.
11 recurrent t(11;18)(q21;q21) translocation in MALT lymphoma.
12 pe 4 (CXCR4) has been previously observed in MALT lymphoma.
13 bacter pylori-positive gastritis and gastric MALT lymphoma.
14 of-function mechanism in the pathogenesis of MALT lymphoma.
15 iological, and molecular genetic features of MALT lymphoma.
16 ular mechanisms of primary SS and primary SS/MALT lymphoma.
17 , both proteins are translocation targets in MALT lymphoma.
18 lize and optimize treatment of patients with MALT lymphoma.
19 clinical management of patients with gastric MALT lymphoma.
20 have been implicated in the pathogenesis of MALT lymphoma.
21 on potentially bridges LELs to genesis of SG-MALT-lymphoma.
22 gastritis and other low-grade gastric B-cell MALT lymphomas.
23 cosal B-cell traffic are also operational in MALT lymphomas.
24 come in the management of gastric, low-grade MALT lymphomas.
25 clones of concurrent gastric and intestinal MALT lymphomas.
26 nt role in the clonal expansion of low-grade MALT lymphomas.
27 the time being in patients with other non-GI MALT lymphomas.
28 otic therapy in nongastrointestinal (non-GI) MALT lymphomas.
29 alternative to radiotherapy for conjunctival MALT lymphomas.
30 not as favorable as the treatment results of MALT lymphomas.
31 a state-of-the-art summary of ocular adnexal MALT lymphomas.
32 c signaling and implicate its dysfunction in MALT lymphomas.
33 on to the IGH locus can promote formation of MALT lymphomas.
34 ll these low-grade lesions are classified as MALT lymphomas.
35 pathogenetic pathways in the development of MALT lymphomas.
36 ased on the distinction between MALT and non-MALT lymphomas.
37 cation of mucosa-associated lymphoid tissue (MALT) lymphoma.
38 2;q32) of mucosa-associated lymphoid tissue (MALT) lymphoma.
39 cation in mucosa-associated lymphoid tissue (MALT) lymphoma.
40 cation in mucosa-associated lymphoid tissue (MALT) lymphoma.
41 lmarks of mucosa-associated lymphoid tissue (MALT) lymphoma.
42 gastric mucosae-associated lymphoid tissue (MALT) lymphoma.
43 s in some mucosa-associated lymphoid tissue (MALT) lymphomas.
44 ations in mucosa-associated lymphoid tissue (MALT) lymphomas.
46 igin) and mucosa-associated lymphoid tissue (MALT) lymphoma (19 of 45 = 42%) (postgerminal center), b
47 ar lymphoma (3 cases) and mucosa-associated (MALT) lymphoma (3 cases) strong (2+) pRB staining was li
48 20 (6.7%) mucosa-associated lymphoid tissue (MALT) lymphomas, 4 of 42 (9.5%) follicular lymphomas, an
49 ll clone, whereas 15 of 25 t(11;18)-negative MALT lymphomas (60%) showed trisomy of chromosomes 18 (n
50 can occur, and in studies reporting only on MALT lymphomas (884 patients), the 5-year and 10-year di
52 tiple histologic subtypes of lymphoma or non-MALT lymphomas (988 patients) reported local control rat
56 is work establishes a molecular link between MALT lymphoma and ABC-DLBCL, and provides mouse models t
57 niques have aided in the distinction between MALT lymphoma and other lymphoproliferative disorders an
59 (q21;q21) translocation occurs frequently in MALT lymphomas and creates a chimeric NF-kappaB-activati
60 t(11;18)(q21,q21) is found in 30% of gastric MALT lymphomas and is associated with a failure to respo
62 why GPR34 genetic changes associate with SG-MALT-lymphoma and how these mutations contribute to the
63 ge cell lymphoma (LCL) arising subsequent to MALT lymphoma, and 16 controls were tested by FISH using
64 ts with primary SS, patients with primary SS/MALT lymphoma, and subjects without primary SS (non-prim
65 cosal venules are similar in normal MALT and MALT lymphomas, and factors controlling normal mucosal B
66 mphomas have a more indolent course than non-MALT lymphomas, and in the conjunctiva a more conservati
67 ly in aggressive and antibiotic unresponsive MALT lymphomas, and may further implicate the biologic i
68 on to systemic disease seems high, even with MALT lymphomas, and treatment with radiation is still re
72 show that concurrent gastric and intestinal MALT lymphomas are derived from the same clone and sugge
73 depth of infiltration of the wall by gastric MALT lymphoma as measured by endoscopic ultrasound has b
74 disease, mucosa-associated lymphoid tissue (MALT) lymphoma, as well as hyperplastic polyps, hyperpla
75 rin-mediated cell adhesion, while primary SS/MALT lymphoma-associated modules were enriched with gene
76 ixafor-PET for detection of residual gastric MALT lymphoma at follow-up were 97.0%, 95.0%, 100.0%, 10
80 x cases of concurrent gastric and intestinal MALT lymphomas by polymerase chain reaction (PCR) amplif
81 ) and without ("pure" DLBCL) the features of MALT lymphomas, can achieve long-term complete remission
82 cell development, these findings suggest the MALT lymphoma cell of origin may be a germinal center B
84 d from colonization of lymphoid follicles by MALT lymphoma cells, following which the tumor cells wer
86 r gastric mucosa-associated lymphoid tissue (MALT) lymphoma cells preferentially to localize around r
89 f gastric mucosa-associated lymphoid tissue (MALT) lymphoma currently relies on esophagogastroduodeno
90 nvolvement of the marginal zone when gastric MALT lymphomas disseminate to the spleen, which is in ke
91 rminal caspase recruitment domain (CARD), in MALT lymphomas due to the recurrent t(1;14)(p22;q32).
92 e management of patients with ocular adnexal MALT lymphoma, especially monoclonal antibody therapy an
96 chronic gastritis tissue, those with MALT or MALT lymphoma had an increase in PCNA labeling index of
100 gy of the mucosa-associated lymphoid tissue (MALT) lymphomas, has been implicated in inflammatory pro
103 . pylori-associated follicular gastritis and MALT lymphomas high endothelial venules coexpressed muco
104 ents with mucosa-associated lymphoid tissue (MALT) lymphomas (HR = 0.26, 95%CI: 0.11-0.59, p = 0.001)
106 a higher than expected incidence of gastric MALT lymphoma in immunosuppressed transplant recipients
107 iption of mucosa-associated lymphoid tissue (MALT) lymphoma in 1983 rapid advances have been made in
109 have been associated with the development of MALT lymphoma including t(11;18) and alterations in Bcl-
111 1;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma induces proteolytic cleavage of NF-kappaB
115 be involved in the growth of salivary gland MALT lymphomas is further suggested by the noted restric
116 f gastric mucosa-associated lymphoid tissue (MALT) lymphoma is dependent on Helicobacter pylori infec
117 Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is indolent and often associated with Hel
120 enesis of mucosa-associated lymphoid tissue (MALT) lymphomas is associated with independent chromosom
121 g gastric mucosa-associated lymphoid tissue (MALT) lymphoma linked with Helicobacter pylori infection
125 h gastric mucosa-associated lymphoid tissue (MALT) lymphoma, much less is known about the value of an
128 pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma (n = 33) and compared the results to GEP
129 The majority of data were available for MALT lymphoma of the ocular adnexa (OAML) including a to
131 lymphoma (FL), marginal zone lymphoma (MZL), MALT lymphoma or B-small lymphocytic lymphoma (B-SLL) ce
132 s in early MESA-associated lesions represent MALT lymphomas or more benign types of expansions has be
133 have furthered the understanding of gastric MALT lymphoma pathogenesis, clinical behavior, and treat
135 nce imaging (MRI) examinations of 26 gastric MALT lymphoma patients, and 20 [68Ga]Pentixafor-PET/MRI
137 r adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML) is the most common orbital tumor,
139 oma occurred 6 months after excision and the MALT lymphoma remained indolent during the course of her
140 ier work in establishing that salivary gland MALT lymphomas represent a highly selected B-cell popula
141 s for the treatment of patients with gastric MALT lymphoma requiring further treatment beyond H pylor
142 ts with primary SS and those with primary SS/MALT lymphoma revealed pathways and molecular targets as
144 anaplastic large cell (Ki-1+) lymphoma, 0/2 MALT lymphoma) showed hypermethylation of the promoter.
148 the transformation of H. pylori gastritis to MALT lymphoma, the extent of cell proliferation, cell vi
149 g the translocation t(1;18)(q21;q21) forms a MALT lymphoma, the growth of which is independent of H.
151 AI was 3.4- and 1.4-fold higher in MALT and MALT lymphoma tissue, respectively, in the same comparis
153 ed tumor onset and induced transformation of MALT lymphoma to activated B-cell diffuse large-cell lym
154 his truly represented preferential homing of MALT lymphoma to the splenic marginal zone, we have now
156 h gastric mucosa-associated lymphoid tissue (MALT) lymphoma, treatment-related toxicity should be min
160 orambucil Plus Rituximab Versus Rituximab in MALT Lymphoma) was launched to compare chlorambucil alon
163 modules related to primary SS and primary SS/MALT lymphoma were significantly enriched with genes kno
165 een adequately tested only in ocular adnexal MALT lymphomas where upfront doxycycline may be a reason
166 ecutive patients with stage I to IIE gastric MALT lymphoma who obtained a pathologic remission after
167 t endoscopy demonstrated early-stage gastric MALT lymphoma with associated Helicobacter pylori gastri
168 latter patient was found to have high-grade MALT lymphoma with low-grade MALT lymphoma abutting the